|
Posted |
Poster |
Post |
| Sat 09:29 | careful | 247p + shares in kaz could take it well above 300p.
such confusion.
most people are talking gibberish.
will be patient, all will be revealed.
i cannot believe they will get away with cash+shares of below 300p. read more... |
| Fri 18:36 | tanzz786 | 300p plus 30% premium = 390p - thee is also a possibility of a hostile counter bid by KAZ PLUS Suleiman Kerimov nearer 445p - I do not think that independent board will take a bid that seriously undervalues the company without fighting back....this share price movement is based on speculation and rumour mongering - wonder who made a packet shorting the stock today? Blackrock? read more... |
| Fri 16:36 | careful | there must be some scope for negotiation here.
there are a couple of weeks to go.
the first low ball offer will be rejected on behalf of the minority shareholders.
read more... |
| Fri 16:16 | careful | yes, just read the release.
that is probably all that bloomberg knows as well.
are they guessing when they say below 300p, or have they inside info i wonder. read more... |
| Fri 16:10 | dr biotech | Letter doesn't say what the offer is, just that it they are cheapskates. Another 2 weeks leeway too. read more... |
| Fri 16:00 | careful | p.s. i reckon bloomberg may be wrong.
not for the first time. read more... |
| Fri 15:56 | and1 | doesnt kaz have to agree to that offer? why would their oligarchs take such a loss? they plan to remain listed in uk? read more... |